Drug discovery products & services
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
120
NCT05602363
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Phase: Phase 1
Role: Lead Sponsor
Start: Aug 1, 2023
Completion: Sep 30, 2027
Loading map...